Open $48.23
Day Range 47.51 - 48.65
52 Week Range 32.78 - 48.65
Market Cap $271.81B
Shares Outstanding 5.6B
Public Float 5.6B
Beta 0.68
Rev. per Employee $533.86K
P/E Ratio 20.80
EPS $2.34
Yield 3.21%
Dividend $0.39
Ex-Dividend Date Jul 29, 2021
Short Interest 54.5M 07/30/21
% of Float Shorted 0.97%
Average Volume 25.45M

5 Day	5.45%
1 Month	20.76%
3 Month	20.88%
YTD	31.72%
1 Year	33.46%

Sell
Under
Hold
Over
Buy

Number of Ratings 21 Full Ratings

MarketWatch
Dow Jones

Pfizer, BioNTech File Initial Data to FDA to Support Covid-19 Vaccine Booster Dose

Aug. 16, 2021 at 11:54 a.m. ET

Pfizer, BioNTech submit trial data on COVID-19 booster shot to FDA

Aug. 16, 2021 at 11:49 a.m. ET by Tomi Kilgore

Pfizer, BioNTech have submitted Phase 1 data to FDA for evaluation of booster dose of COVID-19 vaccine

Aug. 16, 2021 at 11:34 a.m. ET by Tomi Kilgore

CureVac stock gains after upbeat preclinical data on COVID-19 vaccine candidate on primates

Aug. 16, 2021 at 11:15 a.m. ET by Tomi Kilgore

Barron's

CureVac and GSK Say Second Covid-19 Vaccine Was Better in Preclinical Test

Aug. 16, 2021 at 9:47 a.m. ET by Barron's

Barron's

As Covid Cases Spread, Vaccines Won’t Be Enough

Aug. 16, 2021 at 8:45 a.m. ET by Barron's

U.S. could offer COVID vaccine boosters for elderly as soon as this fall

Aug. 15, 2021 at 4:12 p.m. ET by Associated Press

FDA says doctors can give an extra COVID-19 dose to some people with weak immune systems. This is the first authorization for a booster shot in the U.S.

Aug. 12, 2021 at 3:13 p.m. ET by Jaimy Lee

Face mask fights escalate in Texas and Florida as delta variant of COVID forces Louisiana to send ambulances to other states

Aug. 13, 2021 at 11:25 a.m. ET by Ciara Linnane

Barron's

Covid-19 Cases Are Surging. When Will This Wave Peak?

Aug. 13, 2021 at 8:18 p.m. ET by Barron's

Barron's

Moderna’s Stock Crumbled This Week. Investors Are Questioning Its Spectacular Surge.

Aug. 11, 2021 at 3:41 p.m. ET by Barron's

Opinion

What does full FDA approval of a COVID vaccine mean if it’s already authorized for emergency use?

Aug. 12, 2021 at 3:17 p.m. ET by Jennifer Girotto

Pfizer Inc. stock outperforms market on strong trading day

Aug. 13, 2021 at 5:15 p.m. ET by MarketWatch Automation

Barron's

U.S. Authorizes Third Dose of Covid Vaccines. Don’t Call Them Booster Shots.

Aug. 13, 2021 at 8:07 a.m. ET by Barron's

Moderna stock rallies after FDA OKs booster shot of COVID-19 vaccine for most at-risk adults

Aug. 13, 2021 at 9:21 a.m. ET by Tomi Kilgore

Moderna Shares Climb on Vaccine News

Aug. 13, 2021 at 9:19 a.m. ET

FDA authorizes booster vaccine dose for people with weak immune systems, and WHO to test 3 drugs as possible treatments for hospitalized COVID patients

Aug. 12, 2021 at 10:32 a.m. ET by Ciara Linnane

Pfizer Inc. stock outperforms market on strong trading day

Aug. 12, 2021 at 5:15 p.m. ET by MarketWatch Automation

Barron's

FDA Could Authorize Covid Booster Shots for Immunocompromised. What to Know.

Aug. 12, 2021 at 8:57 a.m. ET by Barron's

Barron's

Mask Mandates Are Spreading Across the U.S. The Delta Wave Is Still Rising.

Aug. 12, 2021 at 10:45 a.m. ET by Barron's

No Headlines Available

Other News
Press Releases

Analysts Love This Newly Formed Healthcare Company; Should You?

Aug. 16, 2021 at 11:01 a.m. ET on Motley Fool

3 Popular Robinhood Dividend Stocks You Can Buy Right Now

Aug. 16, 2021 at 5:52 a.m. ET on Motley Fool

FDA approves Pfizer’s tick-borne encephalitis vaccine

Aug. 16, 2021 at 2:28 a.m. ET on TipRanks.com

Better Dividend Stock: AbbVie or Pfizer?

Aug. 15, 2021 at 11:00 p.m. ET on Motley Fool

4 Reasons to (Still) Be Optimistic About Coronavirus Vaccine Stocks

Aug. 15, 2021 at 8:37 a.m. ET on Motley Fool

4 Pharma Stocks You Can Buy and Hold for 20 Years

Aug. 15, 2021 at 7:03 a.m. ET on Motley Fool

3 Reasons Why You Should Consider Buying Pfizer Stock

Aug. 14, 2021 at 7:03 a.m. ET on Motley Fool

Why Pfizer, BioNTech, and Moderna Stocks Are Getting a Bump Today

Aug. 13, 2021 at 11:15 a.m. ET on Motley Fool

What Rinvoq's Positive News Means for AbbVie

Aug. 13, 2021 at 6:22 a.m. ET on Motley Fool

Why Are Pfizer and Moderna Jacking Up COVID Vaccine Prices?

Aug. 13, 2021 at 6:15 a.m. ET on Motley Fool

Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?

Aug. 12, 2021 at 8:30 a.m. ET on Motley Fool

3 Reasons Why You Might Not Want to Buy Pfizer Stock

Aug. 12, 2021 at 6:15 a.m. ET on Motley Fool

Can Pfizer Seize Share in This Multibillion-Dollar Market?

Aug. 11, 2021 at 1:04 p.m. ET on Motley Fool

3 Pharma Stocks to Buy in August

Aug. 11, 2021 at 6:04 a.m. ET on Motley Fool

Why Shares of BioNTech Were Falling Today

Aug. 10, 2021 at 5:07 p.m. ET on Motley Fool

Why Inovio Pharmaceuticals Is Plunging Today

Aug. 10, 2021 at 2:22 p.m. ET on Motley Fool

Pfizer (PFE) Receives a Hold from Goldman Sachs

Aug. 10, 2021 at 5:17 a.m. ET on TipRanks.com

3 Vaccine Stocks for the Next Decade

Aug. 9, 2021 at 5:00 p.m. ET on Motley Fool

Buying Pfizer Stock Now Could Double Your Money Within 5 Years: Here's How

Aug. 9, 2021 at 5:55 a.m. ET on Motley Fool

Here Are the 12 Best Dividend Stocks I Own Right Now

Aug. 8, 2021 at 5:52 a.m. ET on Motley Fool

No Headlines Available

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Name	Chg %	Market Cap
Johnson & Johnson	0.53%	$463.97B
Eli Lilly & Co.	1.50%	$252.74B
Abbott Laboratories	0.87%	$218.16B
Novartis AG	-0.06%	CHF191.19B
Merck & Co. Inc.	1.28%	$194.21B
Moderna Inc.	-6.59%	$157.33B
AstraZeneca PLC	0.61%	£130.53B
AstraZeneca PLC ADR	1.67%	$180.83B
Bristol Myers Squibb Co.	1.47%	$150.01B
Amgen Inc.	0.97%	$130.42B

Competitor Data Provided By